An elevated serum beta-2-microglobulin level is an adverse...

Cancer 2002 Vol. 95; Iss. 12

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, Ibrahim Barista, Mark A. Hess, Fernando Cabanillas, James D. Cox
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
95
Year:
2002
Language:
english
Pages:
5
DOI:
10.1002/cncr.10998
File:
PDF, 78 KB
english, 2002
Conversion to is in progress
Conversion to is failed